Seeking Alpha

OSI Pharmaceuticals (OSIP) moves up 1.1% as the FDA extends the review date of its lung cancer...

OSI Pharmaceuticals (OSIP) moves up 1.1% as the FDA extends the review date of its lung cancer drug Tarceva 90 days, to April 18.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|